UnitedHealth Aktie News

Some long-term UnitedHealth Group investors are putting their faith in the return of a CEO with a proven track record and a new management team they believe can deliver a turnaround for the historically high-growth Optum health services business and put a tough year behind it.

Historically, UnitedHealth has been a good dividend stock to buy and hold. This year, several issues have weighed on its stock, including rising costs.

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.

UnitedHealth Group Incorporated and Centene Corporation remain heavily discounted after recent selloffs, but are poised for recovery ahead of Q3 earnings. Both UNH and CNC withdrew guidance in 2025 due to rising healthcare utilization and margin pressure, but recent signals suggest stabilization and improving outlooks. CMS's commitment to higher Medicare Advantage rates in 2026 and improving Me...

UnitedHealth Group NYSE: UNH has staged a formidable comeback, with its stock up over 29% in the last 90 days as investors embraced management's aggressive turnaround strategy. This powerful rally has built high expectations, and the market now looks to UnitedHealth Group's third-quarter earnings report on Oct. 28 for the proof needed to sustain the momentum.

UnitedHealth (UNH)'s stock jumped 31% in three months, driven not only by a slight increase in revenue and a high P/E multiple, but also amid mixed signals: a Q2 earnings miss, regulatory scrutiny, and renewed investments in AI. What's behind this volatility?

UnitedHealth's decision to exit 100-plus Medicare Advantage plans was a prudent move. The stock could have significant upside potential as its bottom line improves.

An artificial intelligence system from UnitedHealth Group has reportedly sped up prior authorization requests and reduced medical claims denials “meaningfully” during testing at Minneapolis-based hospital system Allina Health.